Sign inJoin waitlistJoin the waitlist

Mitchell Eric Horwitz

Professor of Medicine · Duke Department of Medicine

Credentials: ·

History

Duke Department of Medicine
Present
Duke Cancer Institute
Present
Duke Regeneration Center
Present

Rush Medical College of Rush University
1992

Research

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
Blood · 2009 · 655 citations
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
Journal of Clinical Oncology · 2017 · Last of 20 authors · 562 citations
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
Journal of Clinical Oncology · 2020 · Last of 22 authors · 389 citations

Nelson Chao
60 papers
Gwynn Long
50 papers
David Rizzieri
48 papers
Cristina Gasparetto
43 papers
Keith Sullivan
37 papers
Anthony Sung
31 papers
Stefanie Sarantopoulos
29 papers
Richard Lopez
23 papers
Taewoong Choi
19 papers
John Chute
18 papers
Richard Maziarz
14 papers
PS
Patrick Stiff
12 papers

Grants

Blood and Marrow Transplant Clinical Trials Network
National Heart, Lung, and Blood Institute · UG1
Contact PI · $1.1M · Duke University
2001–2031

Clinical trials

Prebiotic Galacto-oligosaccharide and Acute GVHD
Principal investigator · Recruiting · Phase 1, Phase 2
University of Kansas Medical Center
2021–2029
Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies
Principal investigator · Completed · Phase 3
Gamida Cell ltd
2020–2025
Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM
Principal investigator · Completed · Phase 1, Phase 2
Gamida Cell ltd
2013–2018
Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant
Principal investigator · Completed · Phase 1
Mitchell Horwitz, MD
2012–2017